Follicular lymphoma grade II, unspecified site is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. This malignancy typically presents with painless lymphadenopathy and can progress to more aggressive forms. Accurate coding with ICD-10 Code C82.10 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this condition effectively.
ICD-10 Code C82.10 represents Follicular lymphoma grade II, unspecified site, a hematological malignancy arising from B-lymphocytes. This code is utilized when the specific site of the lymphoma is not documented, allowing for appropriate billing and clinical documentation. It is crucial for healthcare providers to use this code when diagnosing patients with this condition to ensure accurate treatment and follow-up.
Follicular lymphoma grade II is a slow-growing form of non-Hodgkin lymphoma that arises from B-cells in the lymphatic system. It can lead to significant morbidity if not monitored and treated appropriately. The condition requires medical attention due to its potential to transform into a more aggressive lymphoma.
In clinical workflows, ICD-10 Code C82.10 is used in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management and accurate billing.
ICD-10 Code C82.10 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of follicular lymphoma grade II. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Follicular lymphoma grade II may require hospitalization for treatment initiation or complications. Treatment approaches include chemotherapy, immunotherapy, and targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.10 is critical for billing purposes in hospital, ER, or oncology settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance |
| 96415 | Chemotherapy administration, intravenous, each additional substance |
| 99214 | Established patient office visit, moderate complexity |
| 85025 | Complete blood count with differential |
| 77014 | Ultrasound, breast, unilateral, complete |
Common Questions About Using ICD-10 Code C82.10 for Follicular lymphoma grade II, unspecified site
What are the common symptoms of Follicular lymphoma grade II?
Common symptoms include painless swelling of lymph nodes, fatigue, night sweats, and unintentional weight loss. Patients may also experience fever and itching.
How is Follicular lymphoma grade II diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies (like CT scans), and biopsy of affected lymph nodes to confirm the presence of lymphoma cells.
What treatment options are available for Follicular lymphoma grade II?
Treatment options may include chemotherapy, immunotherapy, and targeted therapies. The choice of treatment depends on the stage of the disease and patient health.
Is Follicular lymphoma grade II curable?
While Follicular lymphoma grade II is generally considered incurable, it can be managed effectively with treatment, leading to prolonged remission and improved quality of life.
How often should patients with Follicular lymphoma grade II be monitored?
Patients should be monitored regularly, typically every 3 to 6 months, with follow-up imaging and blood tests to assess disease progression and treatment response.
Clinical Notes
SOAP notes
DAP notes
AI medical notes